DT
Douglas Tsao HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
124
Avg Return
Past Year
Past Year
5.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
82.4%
Neutral
17.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $232 |
22%
upside
| 2 | +34% |
0
%
| 16 Oct ‘25 5 days ago |
|
|
|
Buy
Reiterated
| $16 |
484%
upside
| 1 | +1.4% |
0
%
| 10 Oct ‘25 11 days ago |
|
|
|
Buy
Reiterated
| $80 |
7%
upside
| 2 | +4.6% |
0
%
| 8 Oct ‘25 13 days ago |
|
|
|
Neutral
Reiterated
| $1 |
29%
downside
| 2 | -9.2% |
0
%
| 30 Sep ‘25 21 days ago |
|
|
|
Buy
Maintained
| $20 |
12%
upside
| 1 | +8.4% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Neutral
Reiterated
| $46 |
46%
upside
| 1 | – |
–
| 9 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $34 |
27%
upside
| 2 | +43% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $35 |
82%
upside
| 1 | -7.1% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $14 |
58%
upside
| 1 | +15% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Buy
Maintained
| $7 |
75%
upside
| 1 | +1.8% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $30 |
69%
upside
| 1 | -13% |
0
%
| 12 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
195%
upside
| 1 | -11% |
0
%
| 6 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $774 |
7%
downside
| 1 | +4.3% |
0
%
| 1 Aug ‘25 2 months ago |
|